跳至主要内容
临床试验/NCT01353105
NCT01353105Unknown4 期

Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion

InCor Heart Institute1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年8月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
发起方
入组人数
20
试验地点
1
主要终点
Respiratory complications (primary graft dysfunction, infection, rejection, bronchiolitis obliterates syndrome)

研究概览

简要总结

Only about 15% of the potential candidates for lung donation are considered suitable for transplantation. A new method for ex vivo lung perfusion (EVLP) has been developed and can be used for evaluation and reconditioning of "marginal" and unacceptable lungs. The ´purpose of this study is to analyse the executability and safety of ex vivo lung perfusion pulmonary ex vivo in marginal donors.

详细描述

Donor Inclusion criteria:

  • Age < 55 years-old;
  • Smoking history < 20 pack-year;
  • Clear chest radiograph;
  • Absence of significant chest trauma;
  • Absence of purulent secretions and gastric contents at bronchoscopy;
  • PaO2 < 300 mm Hg (FIO2 1.0, PEEP 5 cmH2O)

Exclusion criteria:

  • Lungs presenting PO2 < 400 mmHg after ex vivo lung perfusion

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age < 55 years-old;
  • •Smoking history < 20 pack-year;
  • •Clear chest radiograph;
  • •Absence of significant chest trauma;
  • •Absence of purulent secretions and gastric contents at bronchoscopy;
  • •PaO2 < 300 mm Hg (FIO2 1.0, PEEP 5 cmH2O)

排除标准

  • •Lungs presenting PO2 < 400 mmHg after ex vivo lung perfusion

研究组 & 干预措施

Ex vivo lung transplantation

Experimental

single-group studies

干预措施: Ex vivo lung transplantation (Procedure)

结局指标

主要结局

Respiratory complications (primary graft dysfunction, infection, rejection, bronchiolitis obliterates syndrome)

时间窗: 30 days after the ex vivo lung transplantation

30-days mortality

时间窗: 30 days after ex vivo lung transplantation

12-months survival

时间窗: 12 months survival after ex vivo lung transplantation

次要结局

  • Non-respiratory complications (arrhythmia, renal failure, sepsis)(30 days after ex vivo lung transplantation)
  • Oxygenation index (PaO2/FiO2)on ICU arrival and 72 hours(72 hours after ex vivo lung transplantation)
  • Hospital and ICU time of stay(12 months after ex vivo lung transplantation)
  • Mechanical ventilation time(30 days after ex vivo lung transplantation)

研究者

发起方
InCor Heart Institute
申办方类型
Other

研究点 (1)

Loading locations...

相似试验